ondansetron has been researched along with Anemia, Hypoplastic in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe aplastic anemia is a life-threatening bone marrow failure disorder." | 2.70 | Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. ( Brodsky, I; Brodsky, RA; Dorr, D; Jones, RJ; Karp, JE; Lee, SM; Seaman, PJ; Sensenbrenner, LL; Smith, BD, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, RA | 1 |
| Sensenbrenner, LL | 1 |
| Smith, BD | 1 |
| Dorr, D | 1 |
| Seaman, PJ | 1 |
| Lee, SM | 1 |
| Karp, JE | 1 |
| Brodsky, I | 1 |
| Jones, RJ | 1 |
1 trial available for ondansetron and Anemia, Hypoplastic
| Article | Year |
|---|---|
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antiemetics; Cyclophosphamide; Dru | 2001 |